drugset / Trial / NCT05397587
An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This is an open，observational and follow-up clinical trial based on the clinical trial of EV71 vaccine extended age group.The purpose of this study is to evaluate the immunity persistence of EV71 vaccine developed by Sinovac Biotech Co., Ltd in subjects aged 6 \~71 months after full immunization of two doses of vaccine.
Timeline
- Start
- 2022-07-30
- Primary completion
- 2025-07-30
- Completion
- 2025-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enterovirus Type 71 Vaccine（Vero Cell）, Inactivated | Vaccine | 0.5 ml | — |
| Comparator | Menjugate | Vaccine | 0.5 ml | — |